Intravenous Immunoglobulin (IVIg) is used to treat autoimmune or inflammatory diseases, but its mechanism of…
sciencecityDecember 6, 2018
AbCellera announced today its collaboration with Autolus Therapeutics plc (Autolus), a clinical stage biopharmaceutical company…
sciencecityDecember 5, 2018
Parkinson Canada and Brain Canada announced this morning the creation of the Canadian Open Parkinson Network (C-OPN), including a $2-million…
sciencecityDecember 5, 2018
Three researchers from the Michael Smith Laboratories, Drs. Jörg Bohlmann, B. Brett Finlay, and Martin Hirst, are in this…
sciencecityDecember 4, 2018
In 1998, Poul Sorensen’s Lab Discovered a Cancer Mutation. Twenty Years Later, There’s a Drug for It
Two decades ago, Poul Sorensen’s microscope was letting him down. Like so many other pediatric…
sciencecityDecember 4, 2018
A new clinical trial, opening across Canada, is considered a major advancement in precision medicine…
sciencecityDecember 3, 2018
We have known for many years that these first-line responses, which are crucial to fight…
sciencecityDecember 3, 2018
Dr. Peter Zandstra, Director of the School of Biomedical Engineering and Director at the Michael…
sciencecityDecember 3, 2018
CHILDHOOD TRAUMA IS already known for following us into our adult lives — and even to…
sciencecityNovember 30, 2018
